Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Robert N. Mahon"'
Autor:
Ana B. Enriquez, Angelo Izzo, Shannon M. Miller, Erica L. Stewart, Robert N. Mahon, Daniel J. Frank, Jay T. Evans, Jyothi Rengarajan, James A. Triccas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Tuberculosis (TB) remains one of the leading causes of death worldwide due to a single infectious disease agent. BCG, the only licensed vaccine against TB, offers limited protection against pulmonary disease in children and adults. TB vaccine researc
Externí odkaz:
https://doaj.org/article/81e79ce3e4c342ac8953b5b791c71fc5
Autor:
Robert N. Mahon, Richard Hafner
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
To meet the challenges of increasing antimicrobial resistance, the infectious disease community needs innovative therapeutics. Precision medicine and immunotherapies are transforming cancer therapeutics by targeting the regulatory signaling pathways
Externí odkaz:
https://doaj.org/article/f10ebfa90dad4c288760e20f3734e75f
Autor:
Robert N. Mahon, Shabaana A. Khader, Richard Hafner, Jay A. Berzofsky, Ulrich E. Schaible, Suzanne Ostrand-Rosenberg, Gerhard Walzl, Nelita du Plessis, William R. Bishai, Yongjun Sui, Stefan H. E. Kaufmann, Manfred B. Lutz, Dmitry I. Gabrilovich, Ankita Garg, Anca Dorhoi, Leigh A. Kotze
Publikováno v:
J Clin Invest
The critical role of suppressive myeloid cells in immune regulation has come to the forefront in cancer research, with myeloid-derived suppressor cells (MDSCs) as a main oncology immunotherapeutic target. Recent improvement and standardization of cri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38929d369bb7ddec97e0fab37ad20812
https://doi.org/10.1172/jci136288
https://doi.org/10.1172/jci136288
Autor:
Daniel J. Frank, Robert N. Mahon
Publikováno v:
Advances in Host-Directed Therapies Against Tuberculosis ISBN: 9783030569044
Interest in host directed therapy (HDT) for the treatment of tuberculosis (TB) has emerged in recent years as antibiotics have failed to eradicate this disease. Lengthy treatment regimens coupled with the development of drug resistant Mycobacterium t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef2df851bcc5ac95ec5016d99a9c0508
https://doi.org/10.1007/978-3-030-56905-1_1
https://doi.org/10.1007/978-3-030-56905-1_1
Autor:
Larry S. Schlesinger, Maria Lerm, Robert N. Mahon, Paul T. Elkington, Nidhi Kapoor, Deepak Kaushal, Dongeun Huh, Elsje Pienaar
Publikováno v:
J Infect Dis
Despite intensive research efforts, several fundamental disease processes for tuberculosis (TB) remain poorly understood. A central enigma is that host immunity is necessary to control disease yet promotes transmission by causing lung immunopathology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a8dbca6bfa2dc708231d0e94ac9229
https://eprints.soton.ac.uk/427167/
https://eprints.soton.ac.uk/427167/
Autor:
Richard Hafner, Robert N. Mahon
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology
Frontiers in Immunology
To meet the challenges of increasing antimicrobial resistance, the infectious disease community needs innovative therapeutics. Precision medicine and immunotherapy are transforming cancer therapeutics by targeting the regulatory signaling pathways th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::624979144a7ab6053ed8422be3e9900e
Autor:
Robert N. Mahon, Richard Hafner
The lack of novel antimicrobial drugs in development for tuberculosis treatment has provided an impetus for the discovery of adjunctive host-directed therapies (HDTs). Several promising HDT candidates are being evaluated, but major advancement of tub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10178b607ce8cc90f0c409a148d6a3de
https://europepmc.org/articles/PMC4583576/
https://europepmc.org/articles/PMC4583576/